AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Kraig Biocraft Laboratories, Inc.

$0.08 -$0.01 (-6.10%)
OTC · 14 Sep 2026 20:00 UTC
Previous Close
$0.08
Day Range
$0.08$0.09
Year Range
$0.07$0.16
Market Cap
89.04M
AVG Volume
847.53K
Trailing/Forward PE
-21.05/-
PEG ratio
0.47
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD)
010K20K30K24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
KBLB Revenue (USD) by quarter
PeriodRevenue (USD)
26 Q20
26 Q10
25 Q40
25 Q30
25 Q20
25 Q10
24 Q426.92K
24 Q30
24 Q20
24 Q10
Net Income (USD)
-2M-1.5M-1M-500K024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
KBLB Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q2-909.53K
26 Q1-942.72K
25 Q4-787.65K
25 Q3-1.51M
25 Q2-726.13K
25 Q1-600K
24 Q4-851.67K
24 Q3-433K
24 Q2-1.61M
24 Q1-508K
Operating Income (USD)
-1.5M-1M-500K024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
KBLB Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q2-703.43K
26 Q1-825.5K
25 Q4-722.67K
25 Q3-1.43M
25 Q2-637.75K
25 Q1-580K
24 Q4-715.92K
24 Q3-424K
24 Q2-1.49M
24 Q1-449K
EBITDA (USD)
-1.5M-1M-500K024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
KBLB EBITDA (USD) by quarter
PeriodEBITDA (USD)
26 Q2-696.33K
26 Q1-788.07K
25 Q4-635.9K
25 Q3-1.36M
25 Q2-578.31K
25 Q1-454K
24 Q4-709.73K
24 Q3-294K
24 Q2-1.47M
24 Q1-371K
Cash Flows (USD)
-2T-1.5T-1T-500B024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
KBLB Cash Flows (USD) by quarter
PeriodCash Flows (USD)
26 Q2-627.3K
26 Q1-543.83K
25 Q4-1.79T
25 Q3-461.86K
25 Q2-446.91K
25 Q1-434.5K
24 Q4-516.76K
24 Q3-837.04K
24 Q2-510.78K
24 Q1-489.53K
EPS (USD)
-0-0-0024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
KBLB EPS (USD) by quarter
PeriodEPS (USD)
26 Q2-0
26 Q1-0
25 Q4-0
25 Q3-0
25 Q2-0
25 Q1-0
24 Q4-0
24 Q3-0
24 Q2-0
24 Q1-0
Expenses (USD)
-1T01T2T3TR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
KBLB Expenses (USD) by quarter
PeriodExpenses (USD)
26 Q2537.22K
26 Q1647.22K
25 Q42.51T
25 Q31.25M
25 Q2641.53K
25 Q1580.49K
24 Q4720.16K
24 Q3934.57K
24 Q2975.64K
24 Q1448.71K
Cash & Debt (USD)
050B100B150BCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
KBLB Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
26 Q23.39M
26 Q12.89M
25 Q41.79M
25 Q31.57M
25 Q2785.46K
25 Q1397K
24 Q4673.26K
24 Q31.19M
24 Q21.52M
24 Q12.05M
Debt ratios
-0.5-0.2500.250.524 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
KBLB Debt ratios by quarter
PeriodDebt ratios
26 Q20.49
26 Q10.37
25 Q40.03
25 Q3-0.06
25 Q2-0.44
25 Q1-0.44
24 Q4-0.36
24 Q3-0.16
24 Q2-0.06
24 Q10.12
Margins
-50%0%50%100%16 Q316 Q417 Q317 Q418 Q118 Q218 Q318 Q423 Q424 Q4
KBLB Margins by quarter
PeriodMargins
24 Q450%
23 Q4-18.91%
18 Q4100%
18 Q397.95%
18 Q298.11%
18 Q197.35%
17 Q4100%
17 Q389.42%
16 Q4100%
16 Q3100%
Return on Capital
0%10%20%30%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
KBLB Return on Capital by quarter
PeriodReturn on Capital
26 Q213.47%
26 Q113.35%
25 Q49.85%
25 Q318.97%
25 Q28.57%
25 Q17.02%
24 Q410.45%
24 Q35.89%
24 Q223.04%
24 Q18.14%
Shares Outstanding
0500M1B1.5B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
KBLB Shares Outstanding by quarter
PeriodShares Outstanding
26 Q21.11B
26 Q11.09B
25 Q41.06B
25 Q31.07B
25 Q21.05B
25 Q11.04B
24 Q41.04B
24 Q31.04B
24 Q21.04B
24 Q11.04B
Book Value Per Share (USD)
-0.01-0.01-0-0024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
KBLB Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
26 Q2-0.01
26 Q1-0.01
25 Q4-0.01
25 Q3-0.01
25 Q2-0.01
25 Q1-0.01
24 Q4-0.01
24 Q3-0.01
24 Q2-0.01
24 Q1-0.01
Total Assets (USD)
02M4M6M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
KBLB Total Assets (USD) by quarter
PeriodTotal Assets (USD)
26 Q24.27M
26 Q13.72M
25 Q42.57M
25 Q32.36M
25 Q21.59M
25 Q11.32M
24 Q41.51M
24 Q32.03M
24 Q22.22M
24 Q12.77M
Employee Count
02.557.5102014201520162017201820192020
KBLB Employee Count by quarter
PeriodEmployee Count
20207
20195
20189
20177
20165
20152
20142
Free Cash Flow Yield
-3000000%-2000000%-1000000%0%med -2.51%Jan 25May 25Sep 25Jan 26May 26Sep 26
KBLB Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-2020057.33%
Sep 26-1979478.03%
Sep 26-2011383.24%
Aug 26-1890112.12%
Aug 26-1737683.72%
Aug 26-1835477.15%
Aug 26-1753619.23%
Jul 26-1718803.38%
Jul 26-1888513.01%
Jul 26-1659833.34%
Jul 26-1612642%
Jul 26-1483223.48%
Jun 26-1569556.14%
Jun 26-1495358.94%
Jun 26-1480286.93%
Jun 26-1370745.7%
May 26-1349380.5%
May 26-1266277.78%
May 26-1218440.62%
May 26-1184348.54%
May 26-1119377.67%
Apr 26-1138567%
Apr 26-1177104.82%
Apr 26-1230827.34%
Apr 26-1505974.05%
Mar 26-1.46%
Mar 26-1.5%
Mar 26-1.39%
Mar 26-1.28%
Feb 26-1.24%
Feb 26-1.62%
Feb 26-2.16%
Feb 26-2.18%
Jan 26-2.15%
Jan 26-2.1%
Jan 26-2.02%
Jan 26-2.13%
Jan 26-2.04%
Dec 25-2.07%
Dec 25-2.1%
Dec 25-2.05%
Dec 25-2.04%
Nov 25-1.96%
Nov 25-2.05%
Nov 25-2.07%
Nov 25-2.31%
Oct 25-2.44%
Oct 25-2.37%
Oct 25-2.4%
Oct 25-2.33%
Oct 25-2.4%
Sep 25-2.06%
Sep 25-2.48%
Sep 25-2.56%
Sep 25-2.58%
Aug 25-2.67%
Aug 25-2.67%
Aug 25-2.67%
Aug 25-2.66%
Aug 25-2.72%
Jul 25-2.68%
Jul 25-2.7%
Jul 25-2.53%
Jul 25-2.69%
Jun 25-2.69%
Jun 25-2.6%
Jun 25-2.6%
Jun 25-2.5%
May 25-2.77%
May 25-2.66%
May 25-2.58%
May 25-2.55%
May 25-2.47%
Apr 25-2.64%
Apr 25-2.52%
Apr 25-2.6%
Apr 25-2.64%
Mar 25-2.74%
Mar 25-2.48%
Mar 25-2.57%
Mar 25-2.73%
Feb 25-2.38%
Feb 25-2.23%
Feb 25-2.17%
Feb 25-2.16%
Jan 25-2.21%
Jan 25-2.15%
Jan 25-2.25%
Jan 25-2.1%
Jan 25-2.13%
Dec 24-2.12%
Dec 24-2.31%
Dec 24-2.18%
Dec 24-1.84%
Nov 24-2.32%
Nov 24-2.39%
Nov 24-2.24%
Nov 24-1.6%
Nov 24-1.68%
Oct 24-1.65%
Price to Sales
100020003000400050006000med 3202.99Jul 24Oct 24Jan 25May 25Aug 25Dec 25Mar 26
KBLB Price to Sales by quarter
PeriodPrice to Sales
Mar 264730.56
Mar 264602.77
Mar 264976.61
Mar 265377.44
Feb 265559.99
Feb 264266.23
Feb 263194.71
Feb 263174.87
Jan 263214.56
Jan 263296.9
Jan 263416.16
Jan 263246.3
Jan 263381.24
Dec 253337.58
Dec 253293.93
Dec 253377.27
Dec 253389.17
Nov 253532.04
Nov 253373.3
Nov 253330.64
Nov 253595.67
Oct 253405
Oct 253498.39
Oct 253457.14
Oct 253560.65
Oct 253463.37
Sep 254035.41
Sep 253350.52
Sep 253245.45
Sep 253220.15
Aug 253113.14
Aug 253113.14
Aug 253113.14
Aug 253211.27
Aug 253141.63
Jul 253191.93
Jul 253159.43
Jul 253381.51
Jul 253172.58
Jun 253180.32
Jun 253284.78
Jun 253288.65
Jun 253420.2
May 253087.46
May 253211.27
May 253311.87
May 253433.22
May 253545.08
Apr 253317.49
Apr 253471.79
Apr 253359.92
Apr 253318.65
Mar 253190.19
Mar 252176.02
Mar 252098.3
Mar 251980.43
Feb 252266.68
Feb 252422.11
Feb 252486.88
Feb 252499.83
Jan 252445.43
Jan 252515.37
Jan 252396.21
Jan 252575.6
Jan 252538.69
Dec 242550.47
Dec 242333.91
Dec 242478.07
Dec 242940.21
Nov 242331.45
Nov 242258.91
Nov 242409.16
Nov 242460.97
Nov 242339.22
Oct 242389.73
Oct 242313.31
Oct 242201.92
Oct 242383.26
Sep 242252.44
Sep 242358.65
Sep 242396.21
Sep 242317.46
Aug 242519.26
Aug 242526.25
Aug 242533.5
Aug 242935.03
Aug 242694.11
Jul 242940.21
Jul 243160.4
Jul 243414.27
Jul 243626.69
Jun 243315.83
Jun 243885.74
Jun 243648.97
Jun 243419.45
May 243251.07
May 242810.69
May 243323.61
May 243491.99
May 242409.16
Kraig Biocraft Laboratories, Inc.
KBLB
Stockpicker

Video analysis: KBLB

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: KBLB

As New York Fashion Week Kicks Off, Kraig Labs Advances Spider Silk for Fashion's Next Generation of Designers

globenewswire.com · 14 Sep 2026

As New York Fashion Week Kicks Off, Kraig Labs Advances Spider Silk for Fashion's Next Generation of Designers

ANN ARBOR, Mich., Sept. 14, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today highlighted the growing opportunity for advanced biomaterials in fashion as New York Fashion Week begins.

Kraig Biocraft Laboratories Highlighted by Tech Times for Advancing Spider Silk from Science Fiction Toward Commercial Reality

globenewswire.com · 3 Sep 2026

Kraig Biocraft Laboratories Highlighted by Tech Times for Advancing Spider Silk from Science Fiction Toward Commercial Reality

Kraig Labs (OTCQB:KBLB) featured in Tech Times examining the scientific gap between fictional biology and real-world advances in spider silk production.

Kraig Biocraft Laboratories Boosts Spider Silk Output More Than 30% During the Most Technically Challenging Season of the Year

globenewswire.com · 24 Aug 2026

Kraig Biocraft Laboratories Boosts Spider Silk Output More Than 30% During the Most Technically Challenging Season of the Year

Kraig Labs (OTCQB: KBLB) set another spider silk production record, over 30% more than its previous record levels, even during the difficult rainy season

Kraig Biocraft Laboratories CEO Kim Thompson Publishes Thought Leadership Article on the Next Chapter of Authored Biology in Biocompare

globenewswire.com · 10 Aug 2026

Kraig Biocraft Laboratories CEO Kim Thompson Publishes Thought Leadership Article on the Next Chapter of Authored Biology in Biocompare

Kraig Labs (OTCQB: KBLB) CEO published a thought leadership scientific opinion editorial in Biocompare, serving the life sciences and biotech research comm

Kraig Biocraft Laboratories CEO Kim Thompson Featured in Just Style, a Leading Global Apparel Industry Trade Publication

globenewswire.com · 21 Jul 2026

Kraig Biocraft Laboratories CEO Kim Thompson Featured in Just Style, a Leading Global Apparel Industry Trade Publication

Kraig Labs (OTCQB: KBLB) CEO and Founder featured in an in-depth interview published by Just Style, a leading global apparel and textile industry trade pub

Authority Magazine Features Kraig Biocraft Laboratories CEO Kim Thompson as an Industry Disruptor Reshaping the Future of Advanced Materials

globenewswire.com · 10 Jul 2026

Authority Magazine Features Kraig Biocraft Laboratories CEO Kim Thompson as an Industry Disruptor Reshaping the Future of Advanced Materials

Kraig Labs (OTCQB: KBLB) CEO and Founder is featured in Authority Magazine's "Meet the Disruptors" series, a widely read publication on the Medium platform

Kraig Biocraft Laboratories CEO Kim Thompson Highlights Commercial Scale, Competitive Advantages, and the Future of Spider Silk in Featured Pulse 2.0 Interview

globenewswire.com · 15 Jun 2026

Kraig Biocraft Laboratories CEO Kim Thompson Highlights Commercial Scale, Competitive Advantages, and the Future of Spider Silk in Featured Pulse 2.0 Interview

Kraig Labs (OTCQB: KBLB) CEO featured in an extensive interview with Pulse 2.0, where he discussed the Company's technological leadership, commercial produ

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.